Boston Scientific Corp (BSX)

Return on assets (ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 1,850,000 1,789,000 1,825,000 1,771,000 1,593,000 1,228,000 898,000 874,000 656,000 598,000 829,000 755,000 986,000 1,056,000 496,000 177,000 -139,000 3,705,000 3,986,000 4,287,000
Total assets US$ in thousands 39,395,000 38,078,000 37,108,000 36,669,000 35,136,000 34,043,000 33,601,000 32,892,000 32,470,000 31,948,000 32,190,000 32,337,000 32,230,000 31,877,000 31,168,000 30,900,000 30,778,000 30,845,000 30,823,000 30,113,000
ROA 4.70% 4.70% 4.92% 4.83% 4.53% 3.61% 2.67% 2.66% 2.02% 1.87% 2.58% 2.33% 3.06% 3.31% 1.59% 0.57% -0.45% 12.01% 12.93% 14.24%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $1,850,000K ÷ $39,395,000K
= 4.70%

Boston Scientific Corp's return on assets (ROA) has shown some fluctuations over the periods mentioned.

- The ROA was strong in the first half of 2020, above 12%, indicating that the company was effectively utilizing its assets to generate profits during that time.
- However, in the second half of 2020, the ROA turned negative, reaching a low of -0.45% by December 31, 2020. This may indicate that the company was not efficiently utilizing its assets to generate profits during that period.
- The ROA gradually improved in 2021 and 2022, reaching levels between 1.59% and 4.92%. This suggests that Boston Scientific Corp was able to enhance its profitability relative to its total assets during those periods.
- The ROA remained relatively stable around 4.70% from December 31, 2024, indicating that the company maintained a consistent level of profitability relative to its total assets.

In conclusion, Boston Scientific Corp's ROA showed both positive and negative trends over the periods analyzed, with some fluctuations but overall indicating a generally satisfactory performance in terms of asset utilization and profitability.


See also:

Boston Scientific Corp Return on Assets (ROA) (Quarterly Data)